高级检索
当前位置: 首页 > 详情页

The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ER alpha and enhances ER alpha target gene expression in breast cancer cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Fac Med Lab Sci, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Fac Basic Med, Tongren Hosp, Hongqiao Inst Med,Sch Med, Shanghai, Peoples R China [3]Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Clin Lab, Shanghai, Peoples R China [4]Linyi Hosp Tradit Chinese Med, Dept Allergy, Linyi, Shandong, Peoples R China [5]Lanling Peoples Hosp, Dept Gynecol, Lanling, Shandong, Peoples R China [6]Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA [7]Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cellular Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai, Peoples R China
出处:
ISSN:

摘要:
Estrogen/ER signaling is critical for breast cancer progression and therapeutic treatments. Thus, identifying new regulators of this pathway will help to develop new therapeutics to overcome chemotherapy resistance of the breast cancer cells. Here, we report Ajuba directly interacts with ER to potentiate ER target gene expression, and biologically Ajuba promotes breast cancer cell growth and contributes to tamoxifen resistance of these cells. Ajuba constitutively binds the DBD and AF2 regions of ER, and these interactions can be markedly enhanced by estrogen treatment. Mechanistically, Ajuba recruits DBC1 and CBP/p300 and forms a ternary complex to co-activate ER transcriptional activity and concomitantly enhances ER acetylation. Moreover, components of this complex can be found at endogenous promoters containing functional ER responsive elements. Taken together, these data demonstrate that Ajuba functions as a novel co-activator of ER and that Ajuba/DBC1/CBP/p300 ternary complex may be a new target for developing therapeutics to treat breast cancer.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 生物
小类 | 1 区 生化与分子生物学
最新[2023]版:
大类 | 2 区 生物学
小类 | 2 区 生化与分子生物学
JCR分区:
出版当年[2017]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Fac Med Lab Sci, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Fac Basic Med, Tongren Hosp, Hongqiao Inst Med,Sch Med, Shanghai, Peoples R China [3]Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Clin Lab, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Shanghai Jiao Tong Univ, Fac Basic Med, Tongren Hosp, Hongqiao Inst Med,Sch Med, Shanghai, Peoples R China [5]Lanling Peoples Hosp, Dept Gynecol, Lanling, Shandong, Peoples R China [7]Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cellular Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)